Cargando…
Immune checkpoint blockade in HIV
Antiretroviral therapy (ART) has dramatically improved life expectancy for people with HIV (PWH) and helps to restore immune function but is not curative and must be taken lifelong. Achieving long term control of HIV in the absence of ART will likely require potent T cell function, but chronic HIV i...
Autores principales: | Gubser, Celine, Chiu, Chris, Lewin, Sharon R., Rasmussen, Thomas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882999/ https://www.ncbi.nlm.nih.gov/pubmed/35123267 http://dx.doi.org/10.1016/j.ebiom.2022.103840 |
Ejemplares similares
-
GITR activation ex vivo impairs CD8 T cell function in people with HIV on antiretroviral therapy
por: Gubser, Céline, et al.
Publicado: (2023) -
Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy
por: Chiu, Chris Y., et al.
Publicado: (2023) -
Immune-Checkpoint Blockade Therapy in Lymphoma
por: Kuzume, Ayumi, et al.
Publicado: (2020) -
Neutrophils in the era of immune checkpoint blockade
por: Faget, Julien, et al.
Publicado: (2021) -
Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer
por: Chiu, Wei-Chiao, et al.
Publicado: (2022)